MediWound Ltd.
MDWD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $20 | $19 | $26 | $24 |
| % Growth | 8.2% | -29.5% | 11.5% | – |
| Cost of Goods Sold | $18 | $16 | $14 | $16 |
| Gross Profit | $2 | $3 | $12 | $8 |
| % Margin | 8.8% | 15.8% | 46.5% | 34.2% |
| R&D Expenses | $8 | $7 | $10 | $10 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $13 | $11 | $10 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $21 | $18 | $20 | $19 |
| Operating Income | -$19 | -$16 | -$8 | -$11 |
| % Margin | -95.9% | -83% | -28.9% | -47.2% |
| Other Income/Exp. Net | -$11 | $9 | -$12 | -$2 |
| Pre-Tax Income | -$30 | -$7 | -$20 | -$14 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$30 | -$7 | -$20 | -$14 |
| % Margin | -149.5% | -35.9% | -74% | -57% |
| EPS | -3.03 | -0.75 | -3.93 | -3.48 |
| % Growth | -304% | 80.9% | -12.9% | – |
| EPS Diluted | -3.03 | -0.75 | -3.93 | -3.48 |
| Weighted Avg Shares Out | 10 | 9 | 5 | 4 |
| Weighted Avg Shares Out Dil | 10 | 9 | 5 | 4 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$28 | -$5 | -$18 | -$12 |
| % Margin | -139.1% | -26.2% | -68.3% | -51% |